Vanta Bioscience Quarterly Results - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

Vanta Bioscience Quarterly Results    (VANB)

Here are the latest quarterly results of Vanta Bioscience. For more details, see the Vanta Bioscience financial fact sheet and Vanta Bioscience share price and chart. For a sector overview, read our pharmaceuticals sector report.

Excel Export | Annual Financial Info | Result Scoreboard

Vanta Bioscience Quarterly Results

No record found

More Miscellaneous Company Quarterly Results:   BALAXI PHARMA  ALPA LAB  STRIDES PHARMA SCIENCE  CORAL LAB.  ALEMBIC PHARMA  

Compare VANTA BIOSCIENCE With:   BALAXI PHARMA  ALPA LAB  STRIDES PHARMA SCIENCE  CORAL LAB.  ALEMBIC PHARMA  



Today's Market

Sensex, Nifty Continue Downtrend to End Lower for 4th Day; Metal & IT Stocks Drag(Closing)

After opening the day on a positive note, Indian share markets witnessed volatile trading activity throughout the day today and ended lower.

Views on news

Demerger of Financial & Pharma Businesses puts Piramal Enterprises in Limelight (Views On News)

Oct 8, 2021

The company's shareholders will be issued 4 shares in the demerged entity for every 1 held in Piramal Enterprises.

Block Deal Disappoints Max Healthcare Shareholders. Stock Falls 6% (Views On News)

Sep 30, 2021

The divestment of 6.6% stake by the promoter is considered to be one of the largest block deals of the market.

5 Indian Pharma Companies Riding the Vaccination Wave (Views On News)

Sep 3, 2021

These companies are likely to benefit the most from Covid-19 vaccines.

Apollo Hospitals' Shares Rally Over 5%, Hit Record-High on Strong Results (Views On News)

Aug 16, 2021

The company reported a 73% YoY increase in revenue driven by an uptick in the hospital and pharmacy business.

J B Chemicals & Pharma's Decent Performance Puts Stock in Focus (Views On News)

Aug 13, 2021

The company seeks to expand the market for prescription lozenges with new launches this year.

More Views on News

Most Popular

Is it Time to Switch from Tata Power to NTPC? (Profit Hunter)

Oct 11, 2021

Given the huge run up in Tata Power, does it make sense to switch to NTPC?

Modi's Big Move Could Boost these 5 Defence Stocks (Views On News)

Oct 11, 2021

To corporatise the defence sector, the Ministry of Defence (MoD) has dissolved the 250-year-old Ordnance Factory Board (OFB).

5 Green Energy Stocks to Watch as India Readies for a Revolution (Views On News)

Oct 13, 2021

The excitement around green energy stocks has opened up a huge contrarian opportunity in the traditional energy space.

Could HDFC Bank be a Big EV Winner? The Answer Will Surprise You... (Profit Hunter)

Oct 13, 2021

Why should investors take it for granted that India's Tesla will be one of the major auto stocks?

Massive Surge in the Shares of Tata Motors Today. Key Factors Favouring the Rally (Views On News)

Oct 13, 2021

Tata Motors zooms 23% after report of TPG investing Rs 75 bn in EV arm.

More

Become A Smarter Investor
In Just 5 Minutes

Multibagger Stock Guide 2022
Get our special report Multibagger Stocks Guide (2022 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

VANTA BIOSCIENCE SHARE PRICE


Oct 22, 2021 (Close)

TRACK VANTA BIOSCIENCE

  • Track your investment in VANTA BIOSCIENCE with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON VANTA BIOSCIENCE

VANTA BIOSCIENCE 5-YR ANALYSIS

COMPARE VANTA BIOSCIENCE WITH

MARKET STATS